文献速递主动脉疾病

结缔组织病类型影响胸腹主动脉开放重建术后分支通畅性

Connective tissue disease type mediates branch patency of grafts in open thoracoabdominal aortic reconstruction.
PubMed 文献 · J Vasc Surg · 2021-06-26

单中心回顾性研究纳入2006至2020年172例开放分支胸腹主动脉替换患者,其中45例结缔组织病(CTD)患者(32例马凡综合征、5例Loeys-Dietz综合征、8例其他CTD)。CTD患者Ⅱ型动脉瘤更多、重建分支更多、内脏分支重建更频繁、术中出血量更大;马凡综合征患者术后分支通畅性显著优于非CTD患者,但CTD组与非CTD组间各分支通畅性无显著差异。

要点

  • CTD患者开放胸腹主动脉重建更复杂,输血和术后血栓栓塞事件增加。
  • 马凡综合征患者5年分支通畅性显著高于非CTD患者(98.9% vs 89.1%)。

核心结论

  • CTD患者开放胸腹主动脉重建技术挑战大,输血和术后血栓栓塞事件增加,但技术结果优异且与基因型差异相关。
  • 马凡综合征患者分支通畅性显著优于非CTD患者和其他CTD患者,驱动因素多元。

研究设计与样本

  • 单中心回顾性队列研究,纳入2006至2020年所有开放分支胸腹主动脉替换患者,共172例,平均随访30.5±34.9个月。
  • 根据基因型文档将患者分为CTD组(45例,26%)和非CTD组,CTD组包括32例马凡综合征、5例Loeys-Dietz综合征和8例其他CTD。
  • 采用方差分析和χ2检验比较连续与离散变量,Kaplan-Meier曲线分析移植分支通畅性。

主要发现

  • 马凡综合征患者1年和5年总体分支通畅性显著高于非CTD患者(5年98.9% vs 89.1%),非CTD与其他CTD亚组间无显著差异,主要因早期通畅性丧失。

临床怎么用

  • 对CTD患者行开放胸腹主动脉重建应预见更高输血需求和术后血栓栓塞风险。
  • 马凡综合征患者分支通畅性较好,但其他CTD亚组早期通畅性丧失风险需关注。
  • 肾分支通畅性低于内脏分支,术后需加强监测。

局限性

  • 单中心回顾性研究,样本量有限(172例),CTD亚组样本量小。
  • 平均随访时间30.5±34.9个月,部分亚组长期通畅性数据可能不充分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite a shared degenerative vascular phenotype, Marfan syndrome (MFS), Loeys-Dietz syndrome (LDS), and other genetically distinct connective tissue diseases (CTDs) have unique extravascular pathologies that impact the outcomes of aortic replacement. The aim of our study was to investigate the association of CTD genotype with postoperative outcomes and branch patency following open thoracoabdominal aortic replacement in a large institutional cohort. METHODS: All patients undergoing open branched thoracoabdominal aortic replacement at a single academic center from 2006 to 2020 were included and classified as CTD or non-CTD based on the presence of genotypic documentation. Outcomes were compared using analysis of variance and χ2 testing for continuous and discrete variables, respectively. Kaplan-Meier curves were utilized to examine patency of graft branches over time. RESULTS: Overall, 172 patients were included, with a mean follow-up of 30.5 ± 34.9 months. CTD was present in 45 patients (26%); specifically, 32 had MFS, five had LDS, and eight had another CTD. Patients with CTDs had more extent II thoracoabdominal aneurysms (40% vs 15%), more reconstructed branches (3.5 vs 1.8), more frequently reconstructed visceral branches (86.7% vs 22.7%), and higher intraoperative blood loss (13.3 vs 6.8 L; all P < .05) compared with non-CTD patients. Patients with MFS were more frequently systemically anticoagulated preoperatively (50% vs 5%) and demonstrated higher rates of postoperative deep vein thrombosis/pulmonary embolism compared with non-CTD patients (9% vs 2%; both P < .05). Five-year renal branch patency was decreased among all patients compared with visceral branches (87.3% vs 95.6%; P = .05), but there were no individual branch patency differences between patients with and without CTDs (P = .086). Overall branch patency at 1 and 5 years was significantly higher in patients with MFS than in non-CTD patients (98.9% vs 89.1% at 5 years); there were no significant patency differences between non-CTD patients and any other CTD subgroup, mostly due to early patency loss. CONCLUSIONS: Open thoracoabdominal reconstruction in patients with CTD is technically challenging and associated with increased transfusion and postoperative thromboembolic events when compared with non-CTD patients. Technical outcomes of the procedure are excellent and are differentially associated with genotype, with patients with MFS experiencing significantly improved branch patency over both non-CTD patients and patients with other CTDs, a finding which has multifactorial drivers.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Sorber R, Bowen CJ, Hicks CW, et al. Connective tissue disease type mediates branch patency of grafts in open thoracoabdominal aortic reconstruction. J Vasc Surg. 2021. PMID: 34186165. doi:10.1016/j.jvs.2021.05.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。